ロード中...
Low-dose salinomycin induces anti-leukemic responses in AML and MLL
Development of anti-cancer drugs towards clinical application is costly and inefficient. Large screens of drugs, efficacious for non-cancer disease, are currently being used to identify candidates for repurposing based on their anti-cancer properties. Here, we show that low-dose salinomycin, a cocci...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5341990/ https://ncbi.nlm.nih.gov/pubmed/27612428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11866 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|